rs140148322

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PP3BP6BS2

The NM_001318895.3(FHL2):​c.337C>T​(p.Arg113Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000467 in 1,613,304 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R113L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00048 ( 0 hom. )

Consequence

FHL2
NM_001318895.3 missense

Scores

14
4
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 6.29

Publications

3 publications found
Variant links:
Genes affected
FHL2 (HGNC:3703): (four and a half LIM domains 2) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. This protein is thought to have a role in the assembly of extracellular membranes. Also, this gene is down-regulated during transformation of normal myoblasts to rhabdomyosarcoma cells and the encoded protein may function as a link between presenilin-2 and an intracellular signaling pathway. Multiple alternatively spliced variants encoding different isoforms have been identified. [provided by RefSeq, Jan 2016]
C2orf49 (HGNC:28772): (chromosome 2 open reading frame 49) Predicted to be involved in embryonic morphogenesis. Located in nucleus. Part of tRNA-splicing ligase complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.784
BP6
Variant 2-105367734-G-A is Benign according to our data. Variant chr2-105367734-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 178036.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS2
High AC in GnomAd4 at 50 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FHL2NM_001318895.3 linkc.337C>T p.Arg113Cys missense_variant Exon 5 of 7 ENST00000530340.6 NP_001305824.1 Q14192-1Q6I9R8Q2XQU9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FHL2ENST00000530340.6 linkc.337C>T p.Arg113Cys missense_variant Exon 5 of 7 1 NM_001318895.3 ENSP00000433567.2 Q14192-1

Frequencies

GnomAD3 genomes
AF:
0.000329
AC:
50
AN:
152154
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000559
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000424
AC:
106
AN:
250176
AF XY:
0.000362
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.000349
Gnomad ASJ exome
AF:
0.000100
Gnomad EAS exome
AF:
0.0000545
Gnomad FIN exome
AF:
0.0000463
Gnomad NFE exome
AF:
0.000743
Gnomad OTH exome
AF:
0.000492
GnomAD4 exome
AF:
0.000482
AC:
704
AN:
1461150
Hom.:
0
Cov.:
31
AF XY:
0.000483
AC XY:
351
AN XY:
726844
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33468
American (AMR)
AF:
0.000291
AC:
13
AN:
44648
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26074
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39670
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86124
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53398
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5766
European-Non Finnish (NFE)
AF:
0.000587
AC:
653
AN:
1111644
Other (OTH)
AF:
0.000464
AC:
28
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
38
76
115
153
191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000329
AC:
50
AN:
152154
Hom.:
0
Cov.:
32
AF XY:
0.000229
AC XY:
17
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41438
American (AMR)
AF:
0.0000655
AC:
1
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000559
AC:
38
AN:
68036
Other (OTH)
AF:
0.000956
AC:
2
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.535
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000522
Hom.:
0
Bravo
AF:
0.000423
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000379
AC:
46
EpiCase
AF:
0.000436
EpiControl
AF:
0.000890

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Primary dilated cardiomyopathy Uncertain:1Benign:1
Jul 03, 2019
Klaassen Lab, Charite University Medicine Berlin
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 12, 2018
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Arg113Cys in exon 4 of FHL2: This variant is not expected to have clinical sig nificance because it has been identified in 0.07% (86/125956) of European chromo somes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.o rg; dbSNP rs140148322). ACMG/AMP Criteria Applied: BS1; PP3. -

Cardiomyopathy Benign:1
Feb 09, 2018
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.87
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Pathogenic
0.39
CADD
Pathogenic
34
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.89
.;.;D;D;D;D;D
Eigen
Pathogenic
0.83
Eigen_PC
Pathogenic
0.78
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Pathogenic
0.99
.;.;.;.;.;.;D
M_CAP
Uncertain
0.13
D
MetaRNN
Pathogenic
0.78
D;D;D;D;D;D;D
MetaSVM
Pathogenic
0.90
D
MutationAssessor
Pathogenic
3.5
.;.;H;H;H;H;H
PhyloP100
6.3
PrimateAI
Uncertain
0.75
T
PROVEAN
Pathogenic
-6.7
.;D;D;D;D;D;D
REVEL
Pathogenic
0.83
Sift
Pathogenic
0.0
.;D;D;D;D;D;D
Sift4G
Uncertain
0.0080
D;D;D;D;D;D;D
Polyphen
1.0
.;.;D;D;D;D;D
Vest4
0.83
MVP
0.98
ClinPred
0.82
D
GERP RS
5.6
Varity_R
0.74
Mutation Taster
=29/71
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140148322; hg19: chr2-105984191; COSMIC: COSV106097848; API